University Hospital for Neurology

301402, 301404, 302019, 302031, 302038, 302043, 302052, 302073, 302074

Dementia, epilepsy, headache, multiple sclerosis and neuroimmunology, neurobiology, neurointensive care medicine, Parkinson’s disease and movement disorders, sleep disorders, and stroke

The Clinical Department of Neurology has 16 research groups and internationally recognised research priorities in the fields of stroke, Parkinson’s disease, rare movement disorders, multiple sclerosis and neuroimmunology, neurocritical care, headache disorders, epilepsy, autonomic disorders and sleep medicine. The Neurobiology Division focuses on modelling neurodegeneration with an emphasis on multiple system atrophy. This allows us to study disease mechanisms and novel therapeutic targets.

The Clinical Department of Neurology has 113 in-patient beds, including a stroke unit (10 in 2024), a neurocritical care unit (10 fully ventilated beds “level-3-ICU”, 10 post-immediate care beds), an epilepsy monitoring unit (4 beds including invasive EEG monitoring) and a dedicated sleep laboratory (6 beds). It acts as a referral centre for the entire spectrum of neurological diseases, covering Tyrol and the neighbouring Austrian federal states. It receives referrals from all over Austria for specialist diagnostic and therapeutic procedures in its main fields of expertise. The large number of patients managed each year (close to 8,813 in-patient admissions and more than 51,743 out-patient treatments in 2024) provides an excellent basis for speciality training and clinically oriented teaching of students. Key collaborations in clinical routine work include joint programmes with the department of Neurosurgery (epilepsy surgery and deep brain stimulation for movement disorders), and with the departments of Neuroradiology, Vascular Surgery and Cardiology (stroke medicine). The core facility of Neuroimaging Research is exclusively dedicated to research, offering unparalleled technical and logistical capabilities for basic and applied neurological research. Our department is home to two dedicated research infrastructures: the Neurobiology division, which specialises in animal modelling of neurodegeneration and stem cell research, and the neurological research laboratory which focuses on biomarker research and neuroimmunology.

The following research professorships have been established in the Clinical Department of Neurology: Neurobiology division (Univ.-Prof. Dr. GK. Wenning §98 † ), Computational Neuroscience (Univ.-Prof. Dr. C. Scherfler), Experimental Neurology (Univ.-Prof. Dr. M. Reindl), Neurology with a focus on Movement Disorders (Univ.-Prof. Dr. K. Seppi), Neurology with a focus on Sleep Medicine (Univ.-Prof. Dr. B. Högl), Neurology with a focus on Stroke Medicine (Univ.-Prof. Dr. St. Kiechl) and Translational Neurodegeneration Research (Univ.-Prof. DDr. N. Stefanova).

Research Group Stroke

Leaders: Univ.-Prof. Dr. Stefan Kiechl, Assoc. Prof. Priv.-Doz. Dr. Michael Knoflach

The stroke research group is a world leader in acute stroke therapy, post-stroke disease management, stroke rehabilitation (Figure 2 – “Intensified post-stroke care improves long-term dysphagia”),

cervical artery dissection, vascular biology and ageing, and atherosclerosis research including mechanisms of early vascular ageing in the young. Funding is provided by the FFG (COMET Centre and K-Project VASCage), FWF, Standortagentur Tyrol, Reformpool, BHF, MRC, NRC, Diabetes UK, Leducq and others. The group operates a number of epidemiological studies (EVA, EVA4YOU, STROKE-CARD Study, STROKE-CARD Registry, Bruneck Study, ARMY and ARFY Studies) as well as retrospective and prospective patient registries (ReSect and ProSect on cervical artery dissections). It also contributes significantly to large research consortia such as ERFC, GBD and NCD-RisC.

Research Group Computational Neuroscience

Leader: Univ.-Prof. Dr. Christoph Scherfler

The group develops and explores mathematical models of structural and functional image analysis for potential translation into the clinical routine. Its main focus is on neurodegenerative Parkinsonian disorders and was recently extended to include neurodegenerative dementia, sleep disorders, brain tumours and intracranial bleeds. The research group is supported by grants from non-profit research collaborations (EU, TWF).

Research Group Cognitive Neurology

Leaders: Ass.-Prof. PD Dr. Atbin Djamshidian-Tehrani, PhD, ao. Univ.-Prof. Mag. Dr. Margarete Delazer

The Cognitive Neurology research group assesses decision-making, emotion recognition via eye tracking (Figure 3 – “Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study”),

motor and cognitive impulsivity and the cognitive biomarkers that predict conversion to manifest disease in patients with a variety of neurological diseases. Ongoing collaborations include interactions with the Movement Disorders, Neuropsychology, Computational Neuroscience and Sleep Medicine research groups at the Department of Neurology. We are also working closely with the Departments of Neuroradiology, Psychiatry and Nuclear Medicine at MUI.

Research Group Sleep Medicine

Leaders: Univ.-Prof. Dr. Birgit Högl, Dr. Ambra Stefani, PhD, Matteo Cesari, PhD

The Sleep Medicine research group is dedicated to investigating neurological disorders of sleep and wakefulness. Our primary areas of focus include isolated REM sleep behaviour disorder and its prodromal phase, restless legs syndrome and narcolepsy as well as other central disorders of hypersomnolence and parasomnias. Our core competences are in developing novel biomarkers (screening, diagnostic and prognostic), artificial intelligence, novel diagnostic methodology and improving understanding of pathophysiology. Our group is leading international guideline development and has a consolidated collaborations with international centres, including Harvard University, Stanford University, McGill University, Hospital Clinic de Barcelona and the Technical University of Munich, among many others. Prof. Högl is the former President of the World Sleep Society. Dr. Ambra Stefani has been awarded the prestigious Max-Kade Research Fellowship and the 2025 Sleep Research Society Rising Star Award Clinician Investigator and is President Elect of the International RBD Study Group. The group is supported by grants from competitive sources (ERAPERMED, FWF, TWF, Dr. Johannes and Herta Tuba Research Funds, MUI Start) and non-profit organisations (German RLS Patients’ Association).

Research Group Headache

Leader: Assoc.-Prof.-Priv.-Doz. Dr. Gregor Brössner

The Headache research group is a leader in developing novel human migraine models and neuroimaging to investigate the pathophysiology of migraine. It also conducts clinical trials in the field of primary headache disorders. The headache outpatient clinic employs doctors who consult with nurses, physiotherapists who collaborate with psychologists, and researchers who engage directly with clinicians. This multidisciplinary symphony orchestrates comprehensive care for over 800 patients each year. As a leading knowledge and innovation hub, it plays a crucial role in shaping the next generation of headache specialists not only in Austria, but worldwide. The centre is also deeply involved in pre- and postgraduate teaching. The Headache research group is funded by industry and competitive sources (ÖAW, MUI Start, ÖKSG).

Research Group Dysautonomia Centre and Clinical Trials in MSA

Leaders: Assoc.-Prof. DDr. Alessandra Fanciulli, Priv.-Doz. Dr. Florian Krismer, PhD

The Dysautonomia Centre at the Neurobiology Division comprises the diagnostic processing, therapeutic management and research of patients with MSA and other disorders of the autonomic nervous system. Our highly interdisciplinary approach, involves cardiology, gastroenterology, neuro-urology, psychiatry and neuroradiology. The group is supported by grants from industry and competitive sources (Mission MSA, Dr. Johannes & Hertha Tuba Foundation, International Parkinson and Movement Disorder Society, FWF, FWF-DACH, parkinsonfonds.nl).

Research Group Movement Disorders

Leaders: Univ.-Prof. Dr. Klaus Seppi , Ass.- Prof-Priv.-Doz. Dr. Atbin Djamshidian, PhD, Priv.-Doz. Dr. Florian Krismer, PhD

The core competences of the Movement Disorders research group include clinical trial methodology and novel therapies, biomarker research, the development of clinical rating scales and neuroimaging, with a particular focus on magnetic resonance imaging. The group is supported by grants from industry and competitive sources (Michael J. Fox Foundation, International Parkinson’s Disease and Movement Disorder Society, ÖPG, ÖGN, FWF, ÖNB, EU: FP8 and Horizon 2020, CHDI foundation, MSA Coalition, TWF).

Research Group at the Centre for Rare Movement Disorders

Leaders: Priv.-Doz.  Dr. Sylvia Bösch MSc, Dr. Wolfgang Nachbauer, PhD, Dr. Elisabetta Indelicato, PhD

The National Centre for Rare Movement Disorders in Innsbruck (CRMDI, Lead: Sylvia Bösch) is a full member of the European Reference Network for Rare Neurological Diseases (ERN-RND). It aims to tackle complex or rare diseases that require highly specialised, multidisciplinary diagnostic and therapeutic knowledge and resources. The core competences of the Centre for Rare Movement Disorders research group include translational medicine, such as biomarker research, cell based disease modelling (induced pluripotent stem cells), the development of care pathways at the European level, as well as the development and validation of clinical rating scales. This includes long-term expertise in early phase clinical trials with novel therapies (gene-therapies) in rare neurological disease. In conjunction with a multi-disciplinary team, the foundation of a national A-Centre for Rare Diseases (Expertise cluster in Austria) within the MUI is planned. The group is supported by grants from industry and competitive sources (European Reference Network for Rare Neurological Diseases (ERN-RND), ENIGMA, Friedreich Ataxia Research Alliance, FWF: E-Rare grant, EU: Bridge grant, Jardin; Global Ataxia Initiative, NAF, EUROSCA, EFACTS, UNIFAI).

Research Group Neurocritical Care and Infectious Diseases of the Nervous System

Leaders: Univ.-Doz. Dr. Bettina Pfausler, Assoc.-Prof. Priv.-Doz. Dr. Ronny Beer, Priv.-Doz. Dr. Raimund Helbok

The research group focuses on both clinical and translational research, encompassing the epidemiology, pathophysiology and clinical as well as therapeutic aspects of life-threatening diseases affecting the central nervous system (CNS), peripheral nervous system (PNS) and neuromuscular system. As one of the leading centres in its field, the group specialises in traumatic brain injury, haemorrhagic stroke, post-cardiac arrest encephalopathy, status epilepticus and neuroinfectious diseases. The group’s work is supported by grants from both industrial partners and competitive funding sources (FWF, EU/CENTER-TBI, NIH/NINDS and NCS – Curing Coma Campaign, EAN/GCS-NeuroCOVID).

Research Group Neuropsychology

Leaders: ao. Univ.-Prof. Mag. Dr. Margarete Delazer, Assoc. Prof. Priv.-Doz. Dr. Laura Zamarian, PhD

The Neuropsychology research group focuses on the cognitive and psychological consequences of brain damage in different neurological conditions. It also aims at elucidating the brain mechanisms that support cognition in the healthy aging population. Main research topics of the group include the investigation of number processing and decision-making behaviour, as well as the rehabilitation and development of training programs for the improvement of cognitive functions. The Neuropsychology research group is supported by funding from competitive sources (EVTZ / Austrian Science Fund FWF).

Research Group Multiple Sclerosis and Neuroimmunology

Leaders: ao. Univ.-Prof. Dr. Florian Deisenhammer, MSc, Univ.-Prof. Mag. Dr. Markus Reindl

The Multiple Sclerosis (MS) and Neuroimmunology research group works on biomarkers for inflammatory demyelinating diseases, focusing on diagnostic aspects using new applications of cerebrospinal fluid analyses and blood markers, as well as treatment monitoring by investigating anti-drug antibodies. Clinically, there is a strong focus on non-pharmacological interventions through physiotherapy, the assessment of comorbidities and long-term outcomes in elderly MS patients. The group is involved in phase 3 and 4 clinical trials and runs prospective cohort studies on MS co-morbidities and age-related factors.

Research Group Neurooncology

Leader: Priv.-Doz. Dr. Martha Nowosielski-Krappinger, PhD

Neurooncology is a multidisciplinary subspeciality in neuroscience dealing with primary and metastatic tumours to the nervous system, as well as non-metastatic neurological complications of systemic cancer. Our research focuses on developing targeted treatments and immunotherapies for brain tumours. We specialise in molecular imaging using novel magnetic resonance imaging and positron emission tomography techniques.

Research Group Neuromuscular Disorders

Leaders: ao. Univ.-Prof. Dr. Wolfgang Löscher, Priv.-Doz. Dr. Julia Wanschitz

The core competence of the Neuromuscular Disorders research group includes morphological studies of muscle and skin innervation in inflammatory myopathies and small fibre neuropathies, clinical ALS and myasthenia gravis research and the investigation of genotype-phenotype correlations. A detailed monocentric study of peripheral nerve involvement in wildtype transthyretin amyloidosis is currently ongoing.

Research Group Epileptology

Leaders: Priv.-Doz. Dr. Iris Unterberger, OA Dr. Gerald Walser

The Epileptology research group is dedicated to the diagnosis, treatment and comorbidities of the epilepsies. The main topics cover the causes of the epilepsies, the effectiveness of antiepileptic drugs, the neuropsychological consequences of seizures/epilepsy, status epilepticus, presurgical evaluation and differential diagnosis. Until 2023, we led the national coordination of the European registry of anti-epileptic drugs during pregnancy (EURAP) (main office in Milan, Italy; Head: Tomson T, Karolinska-Institute, Stockholm, Sweden). Collaborations: German-Swiss-Austrian collaboration to evaluate the diagnosis and outcome of epilepsy surgery patients; German-Swiss-Austrian collaboration to evaluate the natural course and treatment of status epilepticus, International collaboration to better predict the seizure onset zone assessed by SEEG.

Research Group Experimental Neurology

Leader: Univ.-Prof. Mag. Dr. Markus Reindl

The Experimental Neurology research group investigates the pathophysiology of neurological autoimmune diseases with a specific focus on the characterisation of autoantibodies and autoreactive T-cells. Additional research interests are on the role of infections on autoimmune responses in the central nervous system, neuroinflammation, neuronal injury and neurorehabilitation. Our research is supported by the FWF, FFG, other competitive funders and industry.

Neurobiology Division

Leader: Univ.-Prof. DDr. Nadia Stefanova

The research program of the Division of Neurobiology has two pillars of expertise: preclinical and clinical research with specific focus on multiple system atrophy (MSA), a neurodegenerative disease (alpha-synucleinopathy) associated with autonomic failure, ataxia and parkinsonism. The Division of Neurobiology includes the research groups Translational Neurodegeneration Research, Dysautonomia Centre and Clinical Trials in MSA. The preclinical research focuses on basic molecular mechanisms (Figure 1 – “Disease mechanisms of MSA”),

biomarker discovery and new treatment options for neurodegenerative diseases with special emphasis on α-synucleinopathy including Parkinson’s disease (PD) and MSA. We investigate the role of oligomeric α-synuclein to trigger disease-specific phenotypes, the effects of exogenous stress factors and epigenetic modulation in models of α-synucleinopathy, the involvement of glial cells in PD and MSA and the neuroinflammatory mechanisms associated with α-synuclein pathology. Through preclinical screening and target validation for disease modification, we aim to provide rationale for clinical trials in PD and MSA. The clinical research at the Neurobiology Division focuses on autonomic, imaging and laboratory biomarkers to enable early diagnosis, monitoring disease progression, improved symptom management and therapy of MSA. We aim at detailed understanding of the natural disease course, which is an integral part of the planning of future interventional trials in atypical parkinsonian disorders.

Research Group Translational Neurodegeneration Research

Leader: Univ.-Prof. DDr. Nadia Stefanova

The Translational Neurodegeneration Research group aims to advance understanding of the molecular mechanisms leading to neurodegeneration in MSA and PD and to provide preclinical screening and target validation for disease modification in α-synucleinopathy. A further goal of the group is to improve the laboratory-supported differential diagnosis of parkinsonism by implementing novel assays. The group is funded by the Austrian Science Fund (FWF), EU, Mission MSA, Michael J. Fox Foundation (MJFF), Intramural MUI Funding and industry grants.

Research Group Stroke
Mayer-Suess, Lukas; Knoflach, Michael; Peball, Tamara; Mangesius, Stephanie; Steiger, Ruth; Pereverzyev, Sergiy Jr; Lerchner, Hannes; Blache , Ludovic; Mayr, Manuel; Ratzinger, Gudrun; Kiechl, Stefan; Gizewski, Elke R; Pechlaner, Raimund: Cervical Artery Tortuosity Is Associated With Dissection Occurrence and Late Recurrence: A Nested Case-Control Study.
STROKE. 2025;56(2):413-419.
PubMed: 39698737 doi: 10.1161/STROKEAHA.124.049046 IF: 7,9 / ZIT: 0

NCD Risk Factor Collaboration (NCD-RisC): General and abdominal adiposity and hypertension in eight world regions: a pooled analysis of 837 population-based studies with 7·5 million participants.
Lancet. 2024;404(10455):851-863.
PubMed: 39216975 doi: 10.1016/S0140-6736(24)01405-3 IF: 98,4 / ZIT: 7

Willeit, Karin; Boehme, Christian; Toell, Thomas; Tschiderer, Lena; Seekircher, Lisa; Mayer-Suess, Lukas; Komarek, Silvia; Lang, Wilfried; Griesmacher, Andrea; Knoflach, Michael; Willeit, Johann; Kiechl, Stefan; Willeit, Peter: High-Sensitivity Cardiac Troponin T and Cardiovascular Risk After Ischemic Stroke or Transient Ischemic Attack.
JACC ADVANCES 2024 ;3(7):101022.
PubMed: 39130023 doi: 10.1016/j.jacadv.2024.101022 IF: 21,7 / ZIT: 0

Boehme, Christian; Mayer-Suess, Lukas; Mikšová, Dominika; Lang, Wilfried; Knoflach, Michael; Kiechl, Stefan; Austrian Stroke Unit Registry Collaborators: Prime Time for a Trial Assessing Safety of Intravenous Thrombolysis in Patients Treated With Direct Oral Anticoagulants.
STROKE. 2024;55(6):e149-e150.
PubMed: 38666383 doi: 10.1161/STROKEAHA.123.046142 IF: 7,9 / ZIT: 3

Clarke, Robert; Von Ende, Adam; Schmidt, Lukas E; Yin, Xiaoke; Hill, Michael; Hughes, Alun D; Pechlaner, Raimund; Willeit, Johann; Kiechl, Stefan; Watkins, Hugh; Theofilatos, Konstantinos; Hopewell Jemma C; Mayr, Manuel; PROCARDIS Consortium: Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.
CIRCULATION RESEARCH. 2023;132(4):452-464.
PubMed: 36691918 doi: 10.1161/CIRCRESAHA.122.321690 IF: 16,5 / ZIT: 22

Research Group Computational Neuroscience
Defrancesco, Michaela; Marksteiner, Josef;, Lenhart, Lukas; Klingler, Paul; Steiger, Ruth; Gizewski, Elke R; Goebel, Georg; Deisenhammer, Eberhard A; Scherfler, Christoph: Combined cognitive assessment and automated MRI volumetry improves the diagnostic accuracy of detecting MCI due to Alzheimer’s disease.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2025 10;136:111157.
PubMed: 39349216 doi: 10.1016/j.pnpbp.2024.111157 IF: 5,3 / ZIT: 0

Krismer, Florian; Péran, Patrice; Beliveau,Vincent; Seppi, Klaus; Arribarat, Germain; Pavy-Le Traon, Anne; Meissner, Wassilos G; Foubert-Samier, Alexandra; Fabbri, Margherita; Schocke, Michael M; Gordon, Mark Forest; Wenning, Gregor K; Poewe, Werner; Rascol, Oliver; Scherfler, Christoph: Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study.
MOVEMENT DISORDERS. 2024 Jan;39(1):119-129.
PubMed: 37933745 doi: 10.1002/mds.29633. IF: 7,4 / ZIT: 8

Iglseder, Sarah; Iglseder, Anna; Beliveau, Vincent; Heugenhauser, Johanna; Gizewski, Elke R; Kerschbaumer, Johannes; Stockhammer, Günther; Uprimny, Christian; Virgolini, Irene; Dudas, Joszef; Nevinny-Stickel, Meinhard; Nowosielski, Martha; Scherfler, Christoph: Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
JOURNAL OF NEUROONCOLOGY. 2023 164(3):711-720.
PubMed: 37707754 doi: 10.1007/s11060-023-04414-3 IF: 16,4 / ZIT: 3

Research Group Cognitive Neurology
Wittebrood, Casper; Boban, Marina; Cagnin, Annchiara; Capellari, Sabina; De Winter, François-Laurent; Djamshidian, Atbin, González, Manuel Menéndez; Hjermind, Lena E; Krajcovicova, Lenka; Krüger, Johanna; Levin, Johannes; Reetz, Kathrin; Rodriguez Eloy Rodriguez, Rohrer, Jonathan; Van Langenhove, Tim; Reinhard, Carola; Graessner, Holm; Rusina, Robert; Saracino, Dario; Houot, Marion; Seelar, Harro; Vandenberghe, Rik: Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND).
EUROPEAN JOURNAL OF NEUROLOGY. 2024; 31(12):e16446.
PubMed: 39447217 doi: 10.1111/ene.16446 IF: 4,5 / ZIT: 0

Carbone, Federico; Djamshidian, Atbin: Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management.
CNS DRUGS. 2024;38(6):443-457.
PubMed: 38613665 doi: 10.1007/s40263-024-01087-y IF: 7,4 / ZIT: 5

Kawabata, Kazuya; Djamshidian, Atbin; Bagarinao, Epifanio; Weintraub, Daniel; Seppi, Klaus; Poewe, Werner : Cognitive dysfunction in de novo Parkinson disease: Remitting vs. progressive cognitive impairment.
PARKINSONISM & RELATED DISORDERS. 2024; 120:105984.
PubMed: 38198926 doi: 10.1016/j.parkreldis.2023.105984 IF: 3,1 / ZIT: 3

Sidoroff, Victoria; Carbone, Federico; Ellmerer, Philipp; Bair, Stefanie; Hoffmann, Alexandra; Maran, Thomas; Krismer, Florian; Mahlknecht, Philipp; Mair, Katerina; Raccagni, Cecilia; Ndayisaba, Jean-Pierre; Seppi, Klaus; Wenning, Gregor K; Djamshidian, Atbin: Emotion Recognition in Multiple System Atrophy: An Exploratory Eye-Tracking Study.
JOURNAL OF MOVEMENT DISORDERS. 2024; 17(1):38-46.
PubMed: 37748924 doi: 10.14802/jmd.23090 IF: 2,5 / ZIT: 0

Research Group Sleep Medicine
Schormair, Barbara; Zhao, Chen; Bell, Steven; Didriksen, Maria; Nawaz, Muhammad S; Schandra, Nathalie; Stefani, Ambra; Högl, Birgit; Dauvilliers, Yves; Bachmann, Cornelius G; Kemlink, David; Sonka, Karel; Paulus, Walter; Trenkwalder, Claudia; Oertel, Wolfgang H; Hornyak, Magdolna; Teder-Laving, Maris; Metspalu, Andres; Hadjigeorgiou, Georgios M; Polo, Olli; Fietze, Ingo; Ross, Owen A; Wszolek, Zbigniew K; Ibrahim, Abubaker; Bergmann, Melanie; Kittke, Volker; Harrer, Philipp; Dowsett, Joseph; Chenini, Sofiene; Ostrowski, Sisse Rye; Sørensen, Erik; Erikstrup, Christian; Pedersen, Ole B; Topholm Bruun M; Nielsen, Kaspar R; Butterworth, Adam S; Soranzo, Nicole; Ouwehand, Willem H; Roberts, David J; Danesh, John; Burchell, Brendan; Furlotte, Nicholas A; Nandakumar, Priyanka; 23andMe Research Team; D.E.S.I.R. study group; Earley, Christopher J; Ondo, William G; Xiong, Lang; Desautels, Alex; Perola , Vodicka, Pavel; Dina, Christian; Stoll, Monika; Franke, Andre; Lieb, Wolfgang; Stewart, Alexandre FR; Shah, Svati H; Geiger, Christian; Peters, Annette; Rye David B; Rouleau, Guy A; Berger,Klaus; Stefansson, Hereinn; Ullum, Ullum; Stefansson, Kari; Hinds, David A; Di Angelantonio, Emanuele; Oexle, Konrad; Winkelmann, Juliane: Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction.
NATURE GENETICS. 2024;56(6):1090-1099.
PubMed: 38839884 doi: 10.1038/s41588-024-01763-1 IF: 31,8 / ZIT: 9

Ibrahim, Abubaker; Cesari, Matteo; Heidbreder, Anna; Defrancesco, Michaela; Brandauer, Elisabeth; Seppi, Klaus; Kiechl, Stefan; Högl, Birgit; Stefani, Ambra: Sleep features and long-term incident neurodegeneration: a polysomnographic study.
SLEEP. 2024 11;47(3):zsad304.
PubMed: 38001022 doi: 10.1093/sleep/zsad304 IF: 5,3 / ZIT: 5

Lim, Diane C; Najafi, Arezu; Afifi, Lamia; Bassetti, Claudio LA; Buysse, Daniel J; Han, Fang; Högl, Birgit; Melaku, Yohannes Adama; Morin, Charles M; Pack, Allan I; Poyares, Dalva; Somers, Virend K; Eastwood, Peter R; Zee, Phylis C; Jackson, Chand L; World Sleep Society Global Sleep Health Taskforce: The need to promote sleep health in public health agendas across the globe.
LANCET PUBLIC HEALTH. 2023;8(10):e820-e826.
PubMed: 37777291 doi: 10.1016/S2468-2667(23)00182-2 IF: 25,4 / ZIT: 114

Joza, Stephen; Hu, Michele T; Jung, Ki-Young; Kunz, Dieter; Stefani, Ambra; Dušek, Petr; Terzaghi, Michele; Arnaldi, Dario; Videnovic, Aleksandar; Schiess, Mya C; Hermann, Wiebke; Lee, Jee-Young; Ferini-Strambi ,Luigi; Lewis, Simon JG; Leclair-Visonneau, Lauréne; Oertel, Wolfgang H; Antelmi, Elena; Sixel-Döring, Friederike; Cochen De Cock, Valérie; Liguori, Claudio; Liu, Jun; Provini, Federica; Puligheddu, Monica; Nicoletti, Alessandra; Bassetti, Claudia LA; Bušková, Jitka; Dauvilliers, Yves; Ferri, Raffaele; Montplaisir, Jacques Y; Lawton, Michael; Kim, Han-Joon; Bes, Frederik; Högl, Birgit; Šonka, Karel; Fiamingo, Giuseppe; Mattioli, Pietro; Lavadia, Maria Lorena; Suescun, Jessika; Woo, Kyung Ah Woo; Marelli, Sara; Martens Kaylena Ehgoetz; Janzen, Annette; Plazzi, Giuseppe; Mollenhauer, Brit; Fernandes, Mariana; Li, Yuanyuan, Cortelli, Pietro; Figorilli, Michela; Cicero, Calogero Edoardo; Schaefer, Carolin; Guiraud, Lily; Lanza, Giuseppe; Jean-François, Gagnon; Sunwoo, Jun-Sang; Ibrahim, Abubaker; Girtler, Nicola; Trenkwalder, Claudia; Baldelli, Luca; Pelletier, Amelie; Postuma, Ronald B; International REM Sleep Behavior Disorder Study Group: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study.
BRAIN. 2023;146(8):3258-3272.
PubMed: 36881989 doi: 10.1093/brain/awad072 IF: 11,9 / ZIT: 70

Stefani, Ambra; Serradell, Monica; Holzknecht, Evi; Gaig, Carles; Ibrahim, Abubaker; Marrero, Paula; Cesari, Matteo, Pérez-Carbonell, Laura; Brandauer, Elisabeth; Fernández-Arcos, Ana; Bergmann, Melanie; Matos, Nuria; Santamaria, Joan; Högl, Birgit; Iranzo, Alex; Sleep Innsbruck Barcelona (SINBAR) group: Low Specificity of Rapid Eye Movement Sleep Behavior Disorder Questionnaires: Need for Better Screening Methods.
MOVEMENT DISORDERS 2023;38(6):1000-1007.
PubMed: 37147274 doi: 10.1002/mds.29407 IF: 7,4 / ZIT: 13

Research Group Headache
Birkl, Christoph; Filippi, Vera; Steiger, Ruth; Frank, Florian; Magnesius, Stephanie; Gizewski, Elke, Ruth; Broessner, Gregor: Dynamic fluctuations in brain iron content during migraine attacks: insights from relaxometry and diffusion tensor imaging.
FRONTALS IN NEUROLOGY. 2024 Dec 20;15:1422313.
PubMed: 39758781 doi: 10.3389/fneur.2024.1422313 IF: 2,7/ ZIT: 0

Eller, Michael Thomas; Frank, Florian; Kaltseis, Katharina; Karisik, Anel; Knoflach, Michael; Broessner, Gregor: Novel Calcitonin Gene-Related Peptide (CGRP) Interfering Migraine Therapies and Stroke-A Review.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024 Oct 30;25(21):11685.
PubMed: 39519240 doi: 10.3390/ijms252111685 IF: 4,9/ ZIT: 0

Krajnc, Nik; Frank, Florian; Macher, Stefan; Michl, Martin; Müller, Nina; Maier, Sarah; Zaic, Sina; Wöber, Christian; Pemp, Berthold; Broessner, Gregor; Bsteh, Gabriel: Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study.
THE JOURNAL OF HEADACHE AND PAIN. 2024 Jun 4;25(1):92.
PubMed: 38834953 doi: 10.1186/s10194-024-01799-y IF: 7,3/ ZIT: 1

Kaltseis, Katharina; Filippi, Vera; Frank, Florian; Eckhardt, Christine; Schiefecker, Alois; Broessner, Gregor: Monoclonal antibodies against CGRP (R): non-responders and switchers: real world data from an austrian case series.
BMC NEUROLOGY. 2023 Apr 28;23(1):174.
PubMed: 37118682 doi: 10.1186/s12883-023-03203-9 IF: 2,2/ ZIT: 16

Straube, Andreas; Broessner, Gregor; Gaul, Charly; Hamann, Xenia; Hipp, Joachim; Kraya, Torsten; Neeb, Lars: Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway: a subgroup analysis of the Finesse Study.
THE JOURNAL OF HEADACHE AND PAIN. 2023 May 23;24(1):59.
PubMed: 37221478 doi: 10.1186/s10194-023-01593-2 IF: 7,3/ ZIT: 29

Division of Neurobiology
Research Group Translational Neurodegeneration Research and Research Group Dysautonomia Centre and Clinical Trials in MSA
Krismer, Florian; Fanciulli, Alessandra; Meissner G Wassilios; Coon, Elizabeth; Wenning, Gregor K: Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment.
LANCET NEUROLOGY. 2024;23(12):1252-1266.
PubMed: 39577925 doi: 10.1016/S1474-4422(24)00396-X IF: 46,6/ ZIT: 1

Campese, Nicole; Göbel , Georg; Wanschitz, Julia; Schlager, Andreas; Caliò, Bianca; Leys, Fabian; Bower , Pam; Kellerman, Larry; Zamarian, Laura; Bannister, Kirsty; Chaudhuri , Karrol R; Schrag, Anette; Freeman, Roy; Kaufmann, Horacio; Granata, Roberta; Kiechl , Stefan; Poewe, Werner; Seppi, Klaus; Wenning, Gregor; Fanciulli, Alessandra: Pain in Multiple System Atrophy: A Community-Based Survey.
MOVEMENT DISORDERS. 2024;39(10):1784-1798.
PubMed: 39101334 doi: 10.1002/mds.29961 IF: 7,4/ ZIT: 0

Lam, Isabel; Ndayisaba, Alain; Lewis, Amanda J; Fu, YuHong; Sagredo, Giselle T; Kuzkina, Anastasia; Zaccagnini, Ludovica; Celikag, Meral; Sandoe, Jackson; Sanz, Ricardo L; Vahdatshoar, Aazam; Martin, Timothy D; Morshed, Nader; Ichihashi, Toru; Tripathi, Arati; Ramalingam, Nagendran; Oettgen-Suazo, Charlotte; Bartels, Theresa; Boussouf, Manel; Schäbinger, Max; Hallacli, Erinc; Jiang, Xin; Verma, Amrita; Tea, Challan; Wang, Zichen; Hakozaki, Hakozaki; Yu, Xiao; Hyles, Kelly; Park, Chansaem; Wang, Xinyuan; Theunissen, Thorold W; Wang, Haoyi; Jaenisch, Rudolf; Lindquist, Susan; Stevens, Beth; Stefanova, Nadia; Wenning, Gregor; van de Berg, Wilma D J; Luk, Kelvin C; Sanchez-Pernaute, Rosario; Gómez-Esteban, Juan Carlos; Felsky, Daniel; Kiyota, Yasujiro; Sahni, Nidhi; Yi, Stephen; Chung, Chee Yuen; Stahlberg, Henning; Ferrer, Isidro; Schöneberg, Johannes; Elledge, Stephen J; Dettmer, Ulf; Halliday, Glenda M; Bartels, Tim; Khurana, Vikram: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions.
NEURON. 2024 Sep 4;112(17):2886-2909.e16.
PubMed: 39079530 doi: 10.1016/j.neuron.2024.06.002 IF: 14,7/ ZIT: 17

Chia, Ruth; Ray, Annidita; Shah, Zalak; Ding, Jinhui; Ruffo, Paolo; Fujita, Masashi; Menon, Vilas; Saez-Atienzar, Sara; Reho, Paolo; Kaivola, Karri; Walton, Ronald L; Reynolds, Regina H; Karra, Ramita; Sait, Sait; Akcimen, Fulya; Diez-Fairen, Monica; Alvarez, Iganacio; Fanciulli, Alessandra; Stefanova, Nadia; Seppi, Klaus; Duerr, Susanne; Leys, Fabian; Krismer, Florian; Sidoroff, Victoria; Zimprich, Alexander; Pirker, Walter; Rascol, Olivier; Foubert-Samier, Alexandra; Meissner, Wassilios G; Tison, François; Pavy-Le Traon, Anne; Pellecchia, Maria Teresa; Barone, Paolo; Russillo, Maria Claudia; Marín-Lahoz, Juan; Kulisevsky, Jaime; Torres, Soraya; Mir, Pablo; Periñán, Maria Teresa; Proukakis, Christos; Chelban, Viorica; Wu, Lesley; Goh Yee Y; Parkkinen, Laura; Hu, Michele; Kobylecki, Christopher; Saxon, Jennifer A; Rollinson, Sara; Garland, Emily; Biaggioni, Italo; Litvan, Irene; Rubio, Ileana; Alcalay, Roy N; Kwei, Kimberly T; Lubbe, Steven J; Mao, Qinwen; Flanagan, Margaret; Castellani, Rudolph J; Khurana, Vikram Khurana; Ndayisaba, Alain; Calvo, Andrea; Mora, Gabriele; Canosa, Antonio; Floris,Gianluca; Bohanana, Ryan C; Moore, Anni; Norcliffe-Kaufmann, Lucy; Palma, Jose-Alberto; Kaufmann, Horacio; Kim, Changyoun; Iba, Michiyo; Masliah, Eliezer; Dawson, Ted M; Rosenthal, Liana S; Pantelyat, Alexander; Albert, Marilyn S; Pletnikova, Olga; Troncoso, Juan C; Infante, Jon; Lage, Carmen; Sánchez-Juan, Pascual Sánchenz-Juan; Serrano, Geidy E; Beach, Thomas G; Pastor, Pau; Morris, Huw R; Albani, Diego; Clarimon , Jordi; Wenning, Gregor Karl; Hardy, John A; Ryten, Mina; Topol, Eric; Torkamani, Ali; Chiò, Adriano; Bennett, David A; De Jager, Philip L; Low, Philip A; Singer, Wolfgang; Cheshire, William P; Wszolek, Zbigniew K; Dickson, Dennis W; Traynor, Bryan J; Gibbs, Raphael J; Dalgard, Clifton L; Ross, Owen A; Houlden, Henry; Scholz, Sonja W: Genome sequence analyses identify novel risk loci for multiple system atrophy.
NEURON. 2024;112(13):2142-2156.e5.
PubMed: 38701790 doi: 10.1016/j.neuron.2024.04.002 IF: 14,7/ ZIT: 13
Stefanova, Nadia; Wenning, Gregor K: Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms.
Nat Rev Neurosci. 2023 Jun;24(6):334-346.
PubMed: 37085728 doi: 10.1038/s41583-023-00697-7 IF: 28,7/ ZIT: 28

Research Group Movement Disorders
Heim, Beatrice; Mandler, Elias; Peball, Marina; Carbone, Federico, Schwarzová, Katarína; Demjaha, Rina; Tafrali,Cansu; Buchmann, Arabella; Khalil, Michael; Djamshidian, Atbin; Seppi, Klaus: Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington’s disease.
JOURNAL OF NEUROLOGY. 2025 1;272(2):174.
PubMed: 39891767 doi: 10.1007/s00415-025-12901-y. IF: 4,8 / ZIT: 0

Krismer, Florian; Fanciulli, Alessandra; Meissner Wassilos G; Coon, Elizabeth A; Wenning, Gregor K: Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment.
THE LANCET NEUROLOGY. 2024 23(12):1252-1266.
PubMed: 39577925 doi: 10.1016/S1474-4422(24)00396-X IF: 46,6 / ZIT: 0

Peball, Marina; Heim, Beatrice; Carbone, Federico; Schorr, Oliver; Werkmann, Mario; Ellmerer, Philipp; Marini, Kathrin; Krismer, Florian; Knaus, Hans-Günther; Poewe Werner; Djamshidian, Atbin; Seppi, Klaus: Long-term safety and efficacy of open-label nabilone on sleep and pain in Parkinson´s Disease.
NPJ PARKINSONS DISEASE. 2024 15;10(1):61.
PubMed: 38491070 doi: 10.1038/s41531-024-00665-7 IF: 6,7 / ZIT: 0

Krismer, Florian; Péran, Patrice; Beliveau,Vincent; Seppi, Klaus; Arribarat, Germain; Pavy-Le Traon, Anne; Meissner, Wassilos G; Foubert-Samier, Alexandra; Fabbri, Margherita; Schocke, Michael M; Gordon, Mark Forest; Wenning, Gregor K; Poewe, Werner; Rascol, Oliver; Scherfler, Christoph: Progressive Brain Atrophy in Multiple System Atrophy: A Longitudinal, Multicenter, Magnetic Resonance Imaging Study.
MOVEMENT DISORDERS. 2024 Jan;39(1):119-129.
PubMed: 37933745 doi: 10.1002/mds.29633 IF: 7,4 / ZIT: 8

Marini, Kathrin; Seppi, Klaus; Kiechl, Stefan; Stockner, Heike; Willeit, Peter; Willeit, Johann; Djamshidian Atbin; Rungger, Gregorio; Poewe, Werner; Mahlknecht, Phlipp: Comparison of different risk scores for Parkinson disease in a population-based 10-year study.
EUROPEAN JOURNAL OF NEUROLOGY. 2023 30(10):3347-3352.
PubMed: 37422903 doi: 10.1111/ene.15971 IF: 4,5 / ZIT: 2

Research Group at the Centre for Rare Movement Disorders
Indelicato, Elisabetta; Delatycki, Martin B; Farmer, Jennifer; França Jr, Marcondes C; Perlman, Susan; Rai, Myriam; Boesch, Sylvia: A global perspective on research advances and future challenges in Friedreich ataxia.
NATURE REVIEWS NEUROLOGY. 2025 Mar 3. Online ahead of print. Review
PubMed: 40032987 doi: 10.1038/s41582-025-01065-y IF: 28,2 / ZIT: 0

Zech, Michael; Dzinovic, Ivana; Skorvanek, Matej; Harrer, Philip; Necpal, Jan; Kopajtich, Robert; Kittke, Volker; Tilch, Erik; Zhao, Chen; Tsoma, Eugenia; Sorrentino, Ugo; Indelicato, Elisabetta; Stehr, Antonia; Saparov, Alice; Abela, Lucia; Adamovicova, Miriam; Afenjar, Alexandra; Assmann, Birgit; Baloghova, Janette; Baumann, Matthias; Berutti, Riccardo; Brezna, Zuzana; Brugger, Melanie; Brunet,
Theresa; Cogne, Benjamin; Colangelo, Isabel; Conboy, Erin; Distelmaier, Felix; Eckenweiler, Matthias; Garavaglia, Barbara; Geerlof, Arie; Graf, Elisabeth; Hackenberg, Annette; Harvanova, Denisa; Haslinger, Bernhard; Havrankova, Petra; Hoffmann, Georg F; Janzarik, Wibke G; Keren, Boris; Kolnikova, Miriam; Kolokotronis, Konstantinos; Kosutzka, Zuzana; Koy, Anne; Krenn, Martin; Krygier, Magdalena; Kusikova, Katarina; Maier, Oliver; Meitinger, Thomas; Mertes, Christian; Milenkovic, Ivan; Monfrini, Edoardo; Mourao, Andre Santos Dias; Musacchio, Thomas; Nizon, Mathilde; Ostrozovicova, Miriam; Pavlov, Martin; Prihodova, Iva; Rektorova, Irena; Romito, Luigi M; Rybanska, Barbora; Sadr-Nabavi, Ariane; Schwenger, Susanne; Shoeibi, Ali; Sitzberger, Alexandra; Smirnov, Dmitrii; Svantnerova, Jana; Tautanova, Raushana; Toelle, Sandra P; Ulmanova, Olga; Vetrini, Francesco; Vill, Katharina; Wagner, Matias, Weise, David; Zorzi, Giovanna; Di Fonzo, Alessio; Oexle, Konrad; Berweck, Steffen; Mall, Volker; Boesch, Sylvia; Schormair, Barbara; Prokisch, Holger; Jech , Robert; Winkelmann, Juliane: Combined genomics and proteomics unveils elusive variants and vast aetiologic heterogeneity in dystonia.
BRAIN. 2025 Feb 12:awaf059.
PubMed: 39937650 doi: 10.1093/brain/awaf059 IF: 11,9 / ZIT: 0

Indelicato, Elisabetta; Reetz, Kathrin; Maier, Sarah; Nachbauer, Wolfgang; Amprosi, Matthias; Giunti, Paolo; Mariotti, Caterina; Durr Alexandara; de Rivera Garrido Fracisco JR; Klopstock, Thomas; Schöls, Ludger; Klockgether, Thomas; Bürk, Katrin; Pandolfo, Massimo; Didszun, Claire; Grobe-Einsler, Marcus; Nanetti, Lorenzo; Nenning, Lukas; Kiechl, Stefan; Dichtl, Wolfgang; Ulmer, Hanno; Schulz, Jörg B; Boesch, Sylvia: Predictors of Survival in Friedreich´s Ataxia: A prospective Cohort Study.
MOVEMENT DISORDERS. 2024;39(3):510-518.
PubMed: 38140802 doi: 10.1002/mds.29687 IF: 7,4 / ZIT: 9

Grander, Manuel; Haschka, David; Indelicato, Elisabetta; Kremser, Christian; Amprosi, Matthias; Nachbauer, Wolfgang; Henninger, Benjamin; Stefani, Ambra; Högl, Birigit; Fischer, Christine; Seifert, Markus; Kiechl, Stefan; Weiss, Günter; Boesch, Sylvia: Genetic Determined Iron Starvation Signature in Friedreich’s Ataxia.
MOVEMENT DISORDERS. 2024;39(7):1088-1098.
PubMed: 38686449 doi: 10.1002/mds.29819 IF: 7,4 / ZIT: 5

Lynch, David R; Goldsberry, Angie; Rummey, Christian; Farmer, Jennifer; Boesch, Sylvia; Delatycki, Martin B; Giunti, Paola; Hoyle, Chad J; Mariotti, Caterina; Mathews, Katherine D; Nachbauer, Wolfgang; Perlman, Susan; Subramony SH; Wilmot, George Zesiewicz T, Weissfeld L, Meyer C: Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history data.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024;11(1):4-16.
PubMed: 37691319 doi: 10.1002/acn3.51897 IF: 4,4 / ZIT: 26

Indelicato, Elisabetta; Kirchmair, Alexander; Amprosi, Matthias; Steixner, Stephan; Nachbauer, Wolfgang; Eigentler, Andreas; Wahl, Nico; Apostolova, Galina; Krogsdam, Anne; Schneider, Rainer; Wanschitz, Julia; Trajanoski, Julia; Boesch, Sylvia: Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich’s ataxia.
HUMAN MOLECULAR GENETICS. 2023;32(13):2241-2250.
PubMed: 37027192 doi: 10.1093/hmg/ddad051 IF: 3,1 / ZIT: 9

Research Group Neurocritical Care and Infectious Diseases of the Nervous System
Berek, Klaus; Lindner, Anna; Kindl, Philipp; Di Pauli, Franziska; Schiefecker, Alois J; Pfausler, Bettina; Helbok, Raimund; Deisenhammer, Florian; Beer, Ronny; Rass, Verena; Hegen, Harald: Cerebrospinal fluid red blood cells and total protein are associated with clinical outcome in spontaneous subarachnoid hemorrhage.
EUROPEAN JOURNAL OF NEUROLOGY. 2025 Jan;32(1):e16456.
PubMed: 39478314 doi: 10.1111/ene.16456 IF: 4,5 / ZIT: 0

Kofler, Mario; Lindner, Anna; Rass, Verena; Ianosi, Bogdan I; Putnina, Lauma; Kindl, Philipp; Schiefecker Alois J; Gaasch, Maxime; Beer, Ronny; Rhomberg, Paul; Thomé, Claudius; Schmutzhard, Erich; Pfausler, Bettina; Helbok, Raimund: Liberalization of the systemic glucose management is associated with a reduced frequency of neuroglucopenia in subarachnoid hemorrhage patients: an observational cohort study.
NEUROCRITICAL CARE. 2024 Oct 15.
PubMed: 39407074 doi: 10.1007/s12028-024-02126-8 IF: 3,1 / ZIT: 0

Vogetseder, Michael; Rass, Verena; Lindner, Anna; Kindl, Philipp; Kofler, Mario; Lenhart, Lukas; Putnina, Lauma; Helbok, Raimund; Schiefecker, Alois J; Pfausler, Bettina; Grams, Astrid; Beer, Ronny: Follow-up imaging in angiography-negative spontaneous subarachnoid hemorrhage.
WORLD NEUROSURGERY. 2024 Nov;191:e496-e504.
PubMed: 39243972 doi: 10.1016/j.wneu.2024.08.158 IF: 1,9 / ZIT: 0

Rass, Verena; Kindl, Philipp; Lindner, Anna; Kofler, Mario; Altmann, Laus; Putnina, Lauma; Ianosi, Bogdan-Andrei; Schiefecker, Alois J; Beer, Ronna; Pfausler, Bettina; Helbok, Raimund: Blood pressure changes in association with nimodipine therapy in patients with spontaneous subarachnoid hemorrhage.
NEUROCRITICAL CARE 2023 Aug;39(1):104-115.
PubMed: 37308727 doi: 10.1007/s12028-023-01760-y IF: 3,1 / ZIT: 12

Lindner, Anna; Brunelli, Luca; Rass, Verena; Ianosi, Bogdan-Andri; Gaasch, Max; Kofler, Mario; Limmert, Victoria; Schiefecker, Alois J; Pfausler, Bettina; Beer, Ronny; Pucks-Faes, Elke; Helbok, Raimund: Long-Term Clinical Trajectory of Patients with Subarachnoid Hemorrhage: Linking Acute Care and Neurorehabilitation.
NEUROCRITICAL CARE. 2023 Feb;38(1):138-148.
PubMed: 35962231 doi: 10.1007/s12028-022-01572-6 IF: 3,1 / ZIT: 16

Research Group Neuropsychology
Goettfried, Elfriede; Barket, Robert; Hershman R, Delazer, Margarete; Auer, Michael; Berek, Klaus; Ellmerer, Philipp; Seebacher, Barbara; Hegen, Harald; Di Pauli, Franziska; Deisenhammer, Florian; Zamarian L: Face exploration, emotion recognition, and emotional enhancement of memory in relapsing-remitting multiple sclerosis.
PLOS ONE. 2025 Accepted
doi: https://doi.org/10.1371/journal.pone.0319967

Zamarian, Laura; Rass, Verena; Goettfried, Elisabeth; Mayr, Valentina; Carbone, Federico; Kindl, Philipp; Delazer, Margarete; Djamshidian, Atbin; Fanciulli, Alessandra; Mahlknecht, Philipp; Heim, Beatrice; Peball, Marina; Schiefecker, Alois J; Seppi, Klaus; Löffler-Ragg, Judith; Beer, Beer; Pfausler, Bettina; Kiechl, Stefan; Helbok, Raimund: Objective and subjective cognitive outcomes one year after COVID-19.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY. 2024 Sep;11(9):2360-2371.
PubMed: 39031013 doi: 10.1002/acn3.52149 IF: 4,4 / ZIT: 1

Campese, Nicole; Göbel, Georg; Wanschitz, Julia; Schlager, Andreas; Calio, Bianca; Leys, Fabian; Bower, Pam; Kellerman, Larry; Zamarian, Laura; Bannister, Kirsty; Chaudhuri, Kallol Ray; Schrag, Anette; Freeman, Roy; Kaufmann, Horacio; Granata, Roberta; Kiechl, Stefan; Poewe, Werner; Seppi, Klaus; Wenning, Gregor; Fanciulli, Alessandra: Pain in multiple system atrophy: a community-based survey.
MOVEMENT DISORDERS. 2024 Oct;39(10):1784-1798.
PubMed: 39101334 doi: 10.1002/mds.29961 IF: 7,4 / ZIT: 0

Rass, Verena; Altmann, Laus; Zamarian, Laura; Lindner, Anna; Kofler, Mario; Gaasch, Max; Ianosi; Bogdan-Andrei; Putnina, Lauma; Kindl, Philipp; Delazer, Margarete; Schiefecker, Alois, J; Beer, Ronny; Pfausler, Bettina; Helbok, Raimund: Cognitive, Mental Health, Functional, and Quality of Life Outcomes 1 Year After Spontaneous Subarachnoid Hemorrhage: A Prospective Observational Study.
NEUROCRITICAL CARE. 2024 Aug;41(1):70-79.
PubMed: 38129710 doi: 10.1007/s12028-023-01895-y IF: 3,1 / ZIT: 2

Klein, Elise; Zamarian, Laura Kaufmann, Liane: Challenges in Understanding Numerical Learning: Editorial for Brain Sciences Special Issue “Neurocognitive Signatures of Math (Learning) across the Lifespan and Their Interrelation with Other Aspects of Cognition and Emotion”.
BRAIN SCIENCES. 2023;13(3):420.
PubMed: 36979230 doi: 10.3390/brainsci13030420 IF: 2,7 / ZIT: 1

Research Group Multiple Sclerosis and Neuroimmunology
Helmlinger, Birgit; Seebacher, Barbara; Ropele, Stefan; Hechenberger, Stefan Heschl, Bettina; Reishofer, Gernot; Jordan, Sara; Tinauer, Christian; Wurth, Sebastian; Valsasina, Paola; Rocca, Maria Assunta; Filippi, Massimo; Ehling, Rainer; Reindl, Markus; Khalil, Michael; Deisenhammer, Florian; Brenneis, Chrisitian; Enzinger, Christian; Pinter, Daniela:
JOURNAL OF NEUROLOGICAL SCIENCES. 2025 Feb 12;471:123426.
PubMed: 39965306 doi: 10.1016/j.jns.2025.123426 IF: 2,7 / ZIT: 0

Bsteh, Gabriel; Hoepner, Robert; Gernert, Jonathan A; Berek, Klaus; Gradl, Christine; Kliushnikova, Dariia; Damulina, Anna; Traxler, Gerhard; Föttinger, Fabian; Habernig, Sebastian; Krajnc, Nik; Betancourt, Alejandro Xacier León; Ponleitner, Markus; Zrzavy, Tobias; Deisenhammer, Florian; Di Pauli, Franziska; Havla, Joachim; Khalil, Michael; Kümpfel, Tania; Wipfler, Peter; Chan, Andrew; Berger, Thomas; Hammer, Helly; Hegen, Harald: Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome.
EUROPEAN JOURNAL OF NEUROLOGY. 2025 Jan;32(1):e16587.
PubMed: 39686558 doi: 10.1111/ene.16587 IF: 4,5/ ZIT: 0

Bsteh, Gabriel; Aicher, Marie L; Walde, Janette F; Krajnc, Nik; Haider, Lukas; Traxler, Gerhard; Gradl, Christiane; Salmen, Anke; Riedl, Katharina; Poskaite, Paulina; Leyendecker, Philipp; Altmann, Patrick; Auer, Michael; Berek, Klaus; Di Pauli, Franziska; Kornek, Barbara; Leutmezer, Fritz; Rommer, Paulus S; Zulehner, Gudrun; Zrzavy, Tobias; Deisenhammer, Florian; Chan, Andrew; Berger, Thomas; Hoepner, Robert; Hammer, Helly; Hegen, Hegen: Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI Activity.
NEUROLOGY. 2024 Sep 24;103(6):e209752.
PubMed: 39197111 doi: 10.1212/WNL.0000000000209752 IF: 8,4/ ZIT: 3

Banwell, Brenda; Bennett, Jeffrey L; Marignier, Romain; Kim, Ho Jin; Brilot, Fabienne; Flanagan, Eoin P; Ramanathan, Sudarshini; Waters, Patrick; Tenembaum, Silvia; Graves, Jennifer S; Chitnis, Tanuja; Brandt, Alexander U; Hemingway, Cheryl; Neuteboom, Rinze; Pandit, Lekha; Reindl, Markus; Saiz, Albert; Sato, Douglas Kazutoshi; Rostasy, Kevin; Friedemann, Paul; Pittock, Sean J; Fujihara, Kazuo; Palace, Jacqueline: Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
LANCET NEUROLOGY.2023; Mar;22(3):268-282.
PubMed: 36706773 doi: 10.1016/S1474-4422(22)00431-8 IF: 46,6/ ZIT: 675
Hegen, Harald; Walde, Janette; Berek, Klaus; Arrambide, Georgina; Gnanapavan, Sharmilee; Kaplan, Batia; Khalil, Michael; Saadeh, Ruba; Teunissen, Charlotte; Tumani, Hayrettin; Villar, Luisa M; Willrich, Maria Alice V; Zetterberg, Henrik; Deisenhammer, Florian.
MULTIPLE SCLROSIS. 2023 Feb;29(2):169-181.
PubMed: 36453167 doi: 10.1177/13524585221134213 IF: 4,8/ ZIT: 62

Research Group Neurooncology
Heugenhauser, Johanna; Visus, Carmen; Buchroithner, Johann; Marosi, Christine; Rössler, Karl; Felzmann, Thomas; Widhalm, Georg; Iglseder, Sarah; Nowosielski, Martha; Erhart, Friedrich: Towards integrating imaging and immunology in glioblastoma: mapping blood immune system metrics to tumor magnetic resonance image data.
ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2024 Nov 27;12(1):183.
PubMed: 39605095 doi: 10.1186/s40478-024-01888-8 IF: 6,2/ ZIT: 0

Villanueva-Meyer, Javier E; Spyridon Bakas, Tiwari, Pallavi; Lupo, Janine M; Calabrese, Evan; Christos, Davatzikos; Bi, Wenya Linda; Ismail, Marwa; Akbari, Hamed ;Philipp, Lohmann; Booth, Thomas C;
Wiestler, Benedikt; Aerts, Hugo J W L; Rasool, Ghulam; Tonn, Joerg C; Nowosielski, Martha; Jain, Rajan; Colen, Rivka R; Pati, Sarthak; Baid, Ujjwal; Vollmuth, Philipp; Macdonald, David;
Vogelbaum, Michael A; Chang, Susan M; Huang, Raymond Y; Galldiks, Norbert for the Response
Assessment in Neuro Oncology (RANO) group: Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 1: review of current advancements.
LANCET ONCOLOGY. 2024; 25: e581–88.
PubMed: 39481414 doi: 10.1016/S1470-2045(24)00316-4 IF: 41,6/ ZIT: 3
Spyridon, Bakas; Vollmuth, Philipp; Galldiks, Norber; Booth, Thomas C; Aerts, Hugo J W L; Bi, Wenya Linda; Wiestler, Benedikt; Tiwari, Pallavi; Pati, Sarthak; Baid, Ujjwal; Calabrese, Evan; Lohmann, Philipp; Nowosielski, Martha; Jain, Rajan; Colen, Rivka; Ismail, Marwa; Rasool, Ghulam; Lupo, Janine M; Akbari, Hamed; Tonn, Joerg C; Macdonald, David; Vogelbaum, Michael; Chang, Susan M; Davatzikos, Christos; Villanueva-Meyer, Javier E; Huang, Raymond Y for the Response Assessment in Neuro Oncology (RANO) group: Artificial Intelligence for Response Assessment in Neuro Oncology (AI-RANO), part 2: recommendations for standardisation, validation, and good clinical practice.
LANCET ONCOLOGY. 2024 Nov;25(11):e589-e601.
PubMed: 39481415 doi: 10.1016/S1470-2045(24)00315-2 IF: 41,6/ ZIT: 5

Kurz, Sylvia C; Stammberger, Anja; Rosahl, Steffen K; Abrey, Lauren E; Albert, Nathalie L;
Baumgarten, Louisa V; Gempt, Jens; Grosu, Anca-L; Leidgens, Verena; McLean, Anna; Renovanz, Mirjam; Schwarzenberger, Julia; Sevenich, Lisa; Purkart, Tadeja Urbanic; Combs, Stephanie E; Tabatabai, Ghazaleh; Hegi, Monika; Nowosielski, Martha: Towards more Diversity in Neuro-oncology Leadership-the DivINe Initiative.
NEURO-ONCOLOGY. 2023 Dec 8;25(12):2302-2304
PubMed: 37738478 doi: 10.1093/neuonc/noad157 IF: 16,4/ ZIT: 0

Iglseder, Sarah; Iglseder, Anna; Beliveau, Vincent; Heugenhauser, Johanna; Gizewski, Elke R; Kerschbaumer, Johanna; Stockhammer, Guenther; Uprimny, Christian; Virgolini, Irene; Dudas, Jozsef; Nevinny-Stickel, Meinhard; Nowosielski, Martha; Scherfler, Christoph: Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.
JOURNAL OF NEURO-ONCOLOGY. 2023 Sep;164(3):711-720.
PubMed: 37707754 doi: 10.1007/s11060-023-04414-3 IF: 3,2/ ZIT: 3

Research Group Neuromuscular Disorders
Caballero-Ávila, Marta; Martín-Aguilar, Lorena; Pascual-Goñi, Elba; Michael, Milou R; Koel- Simmelink, Marleen JA; Höftberger, Romana; Wanschitz, Julia; Alonso-Jiménez, Alicia; Armangué, Thais; Baars, Adája Elisabeth, Carbayo, Álvaro; Castek, Barbara; Collet-Vidiella, Roger; De Winter, Jonathan; Del Real, Maria Ángeles; Delmont, Emilien; Diamanti, Luca; Doneddu, Pietro Emiliano; Hiew, Fu Liong; Gallardo, Eduard; Gonzalez, Amaia; Grinzinger, Susanne; Horga, Alejandro; Iglseder, Sara; Jacobs, Bart C; Jauregui, Amaia; Killestein, Joep; Pozza, Elisabeth Lindeck; Martínez-Martínez, Laura; Nobile-Orazio, Eduardo; Ortiz, Nicolau; Pérez-Pérez, Helena; Poppert, Kai-Nicolas; Ripellino, Paolo; Roche, Jose Carols; Rodriguez de Rivera, Francisco Javier; Rostasy, Kevin; Sparasci, Davide; Tejada-Illa, Clara; Teunissen, Charlotte C E; Vegezzi, Elisa; Xuclà-Ferrarons, Tomás; Zach, Fabian; Wieske, Luuk; Eftimov, Filip; Lleixà, Cinta; Querol, Luis: Long-Term Follow Up in Anti-Contactin-1 Autoimmune Nodopathy.
ANNALS OF NEUROLOGY. 2025 Mar;97(3):529-541.
PubMed: 39601182 doi: 10.1002/ana.27142 IF: 8,1/ ZIT: 0

Töpf, Ana; Cox, Dan; Zaharieva, Irina T; Di Leo, Valeria; Sarparanta, Jaakko; Jonson, Per Harald; Sealy, Ian M; Smolnikov, Andrei; White, Richard J; Vihola, Anna; Savarese, Marco; Merteroglu, Munise; Wali, Neha; Laricchia, Anna; Venturini, Cristina; Vroling, Bas; Stenton, Sarah L; Cummings, Beryl B; Harris, Elizabeth; Marini-Bettolo, Chiaria; Diaz-Manera, Jordi; Henderson, Matt; Barresi, Rita; Duff, Jennifer; England, Eleina M; Patrick, Jane; Al-Husayni, Sundos; Biancalana, Valerie; Beggs Bodi I, Bommireddipalli, Shobhana; Bönnemann, Carsten G; Cairns, Anita; Chiew, Mei-Ting; Claeys, Kristl G; Cooper, Sandra T; Davis, Mark R; Donkervoort, Sandra; Erasmus, Corrie E; Fassad, Mahmoud R; Genetti, CAsie A; Grosmann, Carla; Jungbluth, Heinz; Kamsteeg, Erik-Jan; Lornage, Xaviére; Löscher, Wolfgang N; Malfatti, Edoardo; Manzur, Adnan; Martí, PIlar; Mongini, Tiziana E; Muelas, Nuria; Nishikawa, Atsuko; O’Donnell-Luria, Anne; Ogonuki, Narumi; O’Grady, Gina; O’Heir, Emily; Paquay, Stéphanie; Phadke, Rahul; Pletcher, Beth A; Romero, Norma B; Schouten, Meyke; Shah, Snehal; Smuts, Izelle; Sznajer, Yves; Tasca, Giorgio; Taylor, Robert W; Tuite, Allysa; Van den Bergh Peter; VanNoy, Grace; Voermans, Nicol C; Wanschitz, Julia V; Wraige, Elizabeth; Yoshimura, Kimihiko; Oates, Emily C; Nakagawa, Osamu; Nishino, Ichizo; Laporte, Jocelyn; Vilchez, Juan J; MacArthur, Daniel G; Sarkozy, Anna; Cordell, Heather; Udd, Bjarne; Busch-Nentwich, Elisabeth; Muntoni, Francesco; Straub, Volker: Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy.
NATURE GENETICS. 2024 Mar;56(3):395-407.
PubMed: 38429495 doi: 10.1038/s41588-023-01651-0 IF: 31,8/ ZIT: 15

Kleinveld, Vera A; Keritam, Omar; Horlings, Corinne G C; Cetin, Hakan; Wanschitz, Julia; Hotter, Anna; Zirch, Laura S; Zimprich, Fritz; Topakian, Raffi; Müller, Petra; Oel, Dierk; Quasthoff, Stefan; Erdler, Marcus; Rauschka, Helmut; Grinzinger, Susanne; Jecel, Julia; Gaulhofer, Petra; Castek, Barbara; Stadler, Klaus; Löscher, Wolfgang N: Multifocal motor neuropathy as a mimic of amyotrophic lateral sclerosis: Serum neurofilament light chain as a reliable diagnostic biomarker.
MUSCLE & NERVE. 2024 Apr;69(4):422-427.
PubMed: 38334356 doi: 10.1002/mus.28054 IF: 2,8/ ZIT: 4

Meyer, Thomas; Dreger, Marie; Grehl, Torsten; Weyen, Ute; Kettemann, Dagmar; Weydt, Patrick; Günther, René; Lingor, Paul; Petri, Susanne; Koch, Jan Christoph; Großkreutz, Julian; Rödiger, Annekathrin; Baum, Petra; Hermann, Andreas; Prudlo, Johannes; Boentert, Matthias; Weishaupt, Jochen H; Löscher, Wolfgang N; Dorst, Johannes; Koc, Yasemin; Bernsen, Sarah; Cordts, Isabell; Vidovic, Maximilian; Steinbach, Robert; Metelmann, Moritz; Kleinveld, Vera E; Norden, Jenny; Ludolph, Albert; Walter, Betram; Schumann, Peggy; Münch, Christoph; Körtvélyessy, Péter; Maier, André: Serum neurofilament light chain in distinct phenotypes of amyotrophic lateral sclerosis: A longitudinal, multicentre study.
EUROPEAN JOURNAL OF NEUROLOGY. 2024 Sep;31(9):e16379.
PubMed: 38859579 doi: 10.1111/ene.16379 IF: 4,5/ ZIT: 5

Krenn, Martin; Sener, Merve; Rath, Jakob; Zulehner, Gudrun; Keritam, Omar; Wagner, Matias; Laccone, Franco; Iglseder, Stephan; Marte, Sonja; Baumgartner, Manuela; Eisenkölbl, Astrid; Liechtenstein, Christian; Rudnik, Sabine; Quasthof, Stefan; Grinzinger, Susanne; Spenger, Johannes; Wortmann, Saskia B; Löscher, Wolfgang N; Zimprich, Fritz; Kellersmann, Anna; Rappold, Mika;· Bernert, Günther; Freilinger, Michael; Cetin, Hakan: The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study.
JOURNAL OF NEUROLOGY. 2023 Feb;270(2):909-916.
PubMed: 36308527 doi: 10.1007/s00415-022-11440-0 IF: 4,8/ ZIT: 14

Research Group Epileptology
Beuchat, Isabelle; Novy, Jan; Alvarez, Vincent; Rosenow, Felix; Kellinghaus, Christoph; Rüegg, Stephan; Tilz, Christian; Trinka, Eugen; Unterberger, Iris; Uzelac, Zeljko; Strzelczyk, Adam; Rossetti, Andrea O: Association of early general anesthesia with outcome in adults with status epilepticus: A propensity – matched observational study.
EPILEPSIA. 2025 Jan;66(1):e7-e13.
PubMed: 39607464 doi: 10.1111/epi.18203 IF: 6,6/ ZIT: 0

Frauscher B, Mansilla D, Abdallah C, Astner-Rohracher A, Beniczky S, Brazdil M, Gnatkovsky V, Jacobs J, Kalamangalam G, Perucca P, Ryvlin P, Schuele S, Tao J, Wang Y, Zijlmans M, McGonigal A: Learn how to interpret and use intracranial EEG findings.
EPILEPTIC DISORDERS. 2024 Feb;26(1):1-59.
PubMed: 38116690 doi: 10.1002/epd2.20190 IF: 2,0/ ZIT: 14

Astner-Rohracher, Alexandra; Ho, Alyssa; Archer, Bartolomei, Fabrice; Brazdil, Milan; Cacic Hribljan M; Castellano, James; Dolezalova, Irena; Fabricius, Martin Ejler; Garcés-Sanchez, Mercedes; Hammam, Kahina; Ikeda, Akio; Ikeda, Kristin; Kahane, Philippe; Kalamangalam, Giridhar; Kalss, Gudrun; Khweileh, Mays; Kobayashi, Katsuya; Kwan, Patrick; Laing, Joshua Andrew; Leitinger, Markus; Lhatoo, Samden; Makhalova, Julia; McGonigal, Aileen; Mindruta, Iona; Mizera, Mary Margaret; Neal, Andrew; Oane, Irina; Parikh, Prachi; Perucca, PIero; Pizzo, Francesca; Rocamora, Rodrigo; Ryvlin, Philippe; San Antonio Arce, Victoria; Schuele, Stephan; Schulze-Bonhage, Andreas; Suller, Marti Ana; Urban, Alexandra; Villanueva, Vincente; Vilella Bertran, Laura; Whatley, Benjamin; Beniczky, Sandor; Trinka, Eugen; Zimmermann, Georg; Frauscher, Birgit: Prognostic value of the 5-SENSE Score to predict focality of the seizure-onset zone as assessed by stereoelectroencephalography: a prospective international multicentre validation study.
BMJ NEUROLOGY OPEN. 2024 Aug 21;6(2):e000765.
PubMed: 39175939 doi: 10.1136/bmjno-2024-000765 IF: 2,1/ ZIT: 0

Beuchat, Isabelle; Novy, Jan; Rosenow, Felix; Kellinghaus, Christoph; Rüegg, Stephan; Tilz, Christian; Trinka, Eugen; Unterberger, Iris; Uzelac, Zeljko; Strzelczyk, Adam; Rossetti, Andrea O: Staged treatment response in status epilepticus: Lessons from the SENSE registry.
EPILEPSIA. 2024 Feb;65(2):338-349.
PubMed: 37914525 doi: 10.1111/epi.17817 IF: 6,6/ ZIT: 12
Schiller; Katharina; Rauchenzauner; Markus; Avidgor, Tamir; Hannan, Sana; Lorenzen, Carlo; Kaml, Manuela; Walser, Gerald; Unterberger, Iris; Filippi, Vera; Broessner, Gregor, Luef, Gerhard: Primary headache types in adult epilepsy patients.
EUROPEAN JOURNAL OF MEDICAL RESEARCH. 2023 Jan 27;28(1):49.
PubMed: 36707895 doi: 10.1186/s40001-023-01023-8 IF: 2,8/ ZIT: 8

Research Group Experimental Neurology
Bauer, Angelika; Boehme, Christian; Mayer-Suess, Lukas; Rudzki, Dagmar; Knoflach, Michael; Kiechl, Stefan; Reindl, Markus: Peripheral inflammatory response in people after acute ischaemic stroke and isolated spontaneous cervical artery dissection.
SCIENTIFIC REPORTS.2024;14(1):12063.
PubMed: 38802464 doi: 10.1038/s41598-024-62557-3 IF: 3,8 / ZIT: 0

Schanda, Katharin; Mariotto, Sara; Rudzki, Dagmar; Bauer, Angelika; Dinoto, Alessandro; Rossi, Patrizia; Ferrari, Sergio; Jarius, Sven; Wildemann, Brigitte; Boso, Federico; Giometto, Bruno; Engels, Daniel; Kümpfel, Tania; Wendel, Eva-Maria; Rostasy, Kevin; Reindl, Markus: Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses?
BRAIN COMMUNICATION.2024;6(2):fcae106.
PubMed: 38576796 doi: 10.1093/braincomms/fcae106 IF: 4,1 / ZIT: 0

Seebacher, Barbara; Helmlinger,Birgit; Pinter, Daniela; Heschl, Bettina; Ehling, Rainer; Hechenberger, Stefanie; Reindl, Markus; Khalil, Michael; Enzinger, Christian; Deisenhammer, Florian; Brenneis, Christian: Actual and Imagined Music-Cued Gait Training in People with Multiple Sclerosis: A Double-Blind Randomized Parallel Multicenter Trial.
NEUROREHABILITATION AND NEURAL REPAIR. 2024;38(8):555-569.
PubMed: 38873806 doi: 10.1177/15459683241260724 IF: 3,7 / ZIT: 5

Banwell, Brenda; Bennett, Jeffrey L; Marignier, Romain; Kim, Ho Jin; Brilot, Fabienne; Flanagan, Eoin P; Ramanathan S, Waters, Patrick; Tenembaum, Silvia; Graves, Jennifer S; Chitnis Tanuja; Brandt, Alexander U; Hemingway, Cheryl; Neuteboom, Rinze; Pandit, Lekha; Reindl, Markus; Saiz, Albert; Sato, Douglas Kazutosshi; Rostasy, Kevin; Friedemann, Paul; Pittock, Sean J; Fujihara , Kazuo; Palace, Jacqueline: Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
LANCET NEUROLOGY. 2023;22(3):268-282.
PubMed: 36706773 doi: 10.1016/S1474-4422(22)00431-8 IF: 46,6 / ZIT: 662

Lerch, Magadalen; Schanda, Kathrin; Lafon, Eliott; Würzner, Reinhard; Mariotto, Sara; Dinoto, Alessandro; Wendel, Eva Maria; Lechner, Christian; Hegen, Hegen; Rostásy, Kevin; Berger , Thomas; Wilflingseder, Doris; Höftberger, Romana; Reindl, Markus: More Efficient Complement Activation by Anti-Aquaporin-4 Compared With Anti-Myelin Oligodendrocyte Glycoprotein Antibodies.
NEUROLOGY, NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2023;10(1):1-11.
PubMed: 36414427 doi: 10.1212/NXI.0000000000200059 IF: 8,3/ ZIT: 20

Research Group Stroke

• Tiroler Wissenschaftsfonds, Lukas Mayer-Süss: Sleep And Vascular hEalth (SAVE), € 99.205,43 –
• Ludwig Boltzmann Society, Lukas Mayer-Süss: PPIE Exploration – Patient Perspective on Young Stroke, € 23.782,80
• Ludwig Boltzmann Society – Clinical Research Groups, Axel Bauer, Lukas Mayer-Süss : Austrian Digital Atrial Fibrillation Screening and Intervention, € 43.103,41
• Ludwig Boltzmann Society – PPIE Call, Christian Böhme, € 12.000,00
• Tiroler Wissenschaftsfonds, Lukas Mayer-Süss , € 39.210
• FFG Comet K Centre VASCage 2 FP, Stefan Kiechl: Research Centre von Vascular Ageing and Stroke,€ 18,4 Mio

Research Group Cognitive Neurology

• FFG Grant, Atbin Djamshidian-Tehrani: Demenzprävention mittels Smart Watches – Wien Graz IBK, ca. € 266k

Research Group Sleep Medicine

• SPRINT Land Tirol, Matteo Cesari, € 299.738
• DGSM Nachwuchsförderung, Matteo Cesari, € 10.000
• FWF, Ambra Stefani: ERA4Health NutriBrain “Alpha-FIT”, € 381.785 for Innsbruck (total €1.870.053)

Research Group Headache

• Österreichische Kopfschmerzgesellschaft (OEKSG): Austrian Migraine Research Collaboration, € 40.000
• TEVA Pharma: MR-Spectroscopy Study: Investigating neurochemical changes in brain metabolism in migraineurs before and after CGRP-Antibody treatment, € 400.000
• MUI Open Access Fonds, Michael Eller: Novel Calcitonin Gene-Related Peptide (CGRP)

Interfering Migraine Therapies and Stroke-A Review, € 2.000

• MUI-START – Co-Investigator, Frank Florian: Validity and feasibility of Magnetic Resonance Spectroscopic-Thermometry at 3T, € 70.000

Division of Neurobiology

Research Group Translational Neurodegeneration Research and Research Group Dysautonomia Centre and Clinical Trials in MSA

• FWF, Antonio Heras-Garvin: Unravelling the pathogenic role of iron dysregulation in MSA. 347.302 €
• Michael J. Fox Foundation, Nadia Stefanova: Dapansutrile, selective oral NLRP3 inhibitor, to mitigate the disease progression of PD: building more pre-clinical evidence towards a clinical trial, 387,206 $
• MUI PhD Research Training Group, Nadia Stefanova: Translational Research in NeuroDegeneration (TReND), 1,196,670 €
• MSA Coalition Seed Grant, Nadia Stefanova: Catalytically active gold nanocrystals for the treatment of MSA, 50,000 $.
• FWF Research Group, Alessandra Fanciulli, MeDeMSA – Medical Decision Making in Multiple System Atrophy, € 1.496.325,58, ,
• TWF, Antonio Heras-Garvin: Transcriptomic profiling of MSA-like disease progression: a potential strategy to identify novel therapeutic targets.39.000€

Research Group Movement Disorders

• FWF FG 2700 (2023-2028): Medical Decision Making in Multiple System Atrophy,

326.009,83 €.

• (TReND), MUIDK-2022-1-1 (2023-2027): Translational Research in NeuroDegeneration, 1.377.241 €.

Research Group at the Centre for Rare Movement Disorders

• ERN RND Registry Activities, 16.800 €
• ERN BRIDGE grant, Systematic review “DBS in monogenic Dystonias”, 15.000 €
• FARA Grant, Elisabetta Indelicato, MD, PhD: Hepcidine in FA Study, 100.000,00 $
• MUI Start, Elisabetta Indelicato, MD, PhD: CACNA1A gait Study, 16.000 €
• FARA; UNIFAI Registry grant, 6.000,00 €
• EFACTS II Registry grant, 15.000 €
• EJ PRD, “PROFA Study”, on-going PROFA II, 2.000 €
• Biogen; Moxie Study; OL Extension study”, 51.000 €

Total = € 221.800, 000

Research Group Neurocritical Care and Infectious Diseases of the Nervous System

• FWF KLIF, Raimund Helbok, Verena Rass, Ronny Beer: Long-term neurological outcome after SARS-CoV-2 infection, 315,340 €.

Research Group Multiple Sclerosis and Neuroimmunology

• Novartis Investigator Initiated Study, Harald Hegen: A Prospective Multicenter Study to Evaluate and Validate Kappa Free Light Chains for Diagnosis and Prediction of Disease Activity in People with Multiple Sclerosis (BRAMS), 239,000 €.
• Austrian MS Society, Michael Auer: Vascular long-term risk of patients with multiple sclerosis (MS Vasc), a prospective cohort study on vascular risk factors in elderly MS patients, € 9.370

Research Group Neurooncology

• ATTRACT trial, Ludwig Boltzmann Society Martha Nowosielski: personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain Tumor TheRApy Clinical Trial (ATTRACT), € 153.412,50

Research Group Neuromuscular Disorders

• Pfizer, Löscher Wolfgang: Neurological manifestations in wild-type transthyretin amyloidosis, 80,682 €.

Research Group Experimental Neurology

• MUI PhD Research Training Group MUIDK-2022-1-2: “CONNECT”, Subprojekt SUB4, Markus Reindl, € 228.540

Research Group Stroke

VASCage; Prof. Qingbo Xu, Zhejiang University, Hangzhou, China; Prof. Guido Krömer, Faculty of Medicine of the University of Paris Cité, Prof. Frank Madeo, Institute of Molecular Biosciences, NAWI Graz, University of Graz; Prof. Manuel Mayr, Imperial College London, British Heart Foundation, Medical University Vienna; Prof. Georg Schett, University Clinic Erlangen; Prof. Eicke Latz, Charité Berlin; Prof. Bernhard Iglseder, University Clinic, Salzburg; Prof. Valeria Caso, Santa Maria della Misericordia Hospital at the University of Perugia, Italy; Prof. Götz Thomalla, University Medical Centre Hamburg – Eppendorf; Prof. Urs Fischer, University Hospital Bern; Prof. Peter Kelly, Mater University Hospital/University College Dublin; Prof. Jesse Dawson, Institute of Cardiovascular and Medical Sciences (P.H., J.D.), University of Glasgow, United Kingdom; Prof. Sean Savitz, Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Centre (UTHealth), Houston, TX, USA; Prof. Emelia Benjamin, Boston University School of Public Health, USA; Prof. Joseph Witztum, University of California San Diego La Jolla CA; Ass. Prof. Christopher Chen, Stanford University School of Medicine, USA; Prof. Frank-Erik de Leeuw, Department of Neurology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; Prof. Martin Dichgans, Ludwig-Maximilians-University Munich, Medical Centre; Prof. Sheila Martins, Federal University of Rio Grande do Sul, Brazil;Prof. Hugh Stephen Markus, Department of Clinical Neurosciences, University of Cambridge, UK; Prof. Bernard Yan, Royal Melbourne Hospital, Australia; Prof. Sylaja PN, Sree Chitra Tirunal Institute for Medical Sciences and Technology; Prof. Ana Catarina Fonseca, University of Lisbon; Prof. Geert Jan Biessels, Department of Neurology, University Medical Centre Utrecht, Netherlands; Prof. Stefanie Debette, University of Bordeaux, France; Fachhochschule Gesundheit; ICVTC (Cerebral Venous Thrombosis Consortium), Inselspital Bern – DO-IT Trial since 08/2024; CHUV (Prof. Patrik Michel) with projects BRAVO (Best Revascularization Approach of isolated Vertebral Artery Occlusions) und pc-CBS (Posterior circulation Clot Burden Score); TENSION-Study collaborators; SWIFT DIRECT collaborators; PACIFIC Stroke Study Group; OCEANIC-Stroke Study Group; Dissection Research Group Bern (Prof. Engelter/Prof. Traenkler).

Research Computational Neuroscience

Prof. David Devos, Department of Medical Pharmacology University of Lille, France

Research Group Cognitive Neurology

Assoc. Prof. Priv. Doz, Dr. E Stögmann, University Hospital Vienna; Assoc. Prof. Sten Hanke, FH Johanneum, University of Applied Sciences, Graz

Research Group Sleep Medicine

Prof. Dr. Emmanuel Mignot, Stanford Sleep Medicine Centre, Stanford University, Stanford, USA;

Prof. Dr. Aleksandar Videnovic, Division of Sleep Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA; Prof. Dr. Alex Iranzo, Sleep Disorders Centre, Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Prof. Dr. Federica Provini (University of Bologna, Italy); Prof. Dr. Claudia Trenkwalder (Paracelsus-Elena-Klinik, Kassel, Germany); Prof. Dr. Isabelle Arnulf (University of Paris Sorbonne, France); Prof. Juliane Winkelmann and Dr. Barbara Schormair (Helmholtz Zentrum, Munich, Germany)

Research Group Headache

Medical University Vienna, Prof. Gabriel Bsteh: Idiopathic intracranial Hypertension (IIH)

Planning Committee – Interlaken Trilateral Conference (Frank Florian)

Research Group Dysautonomia Centre and Clinical Trials in MSA

Prof. Roland Thijs, Department of Neurology, Leiden University Medical Centre, Leiden & Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands; Prof. Mario Habek, Department of Neurology, University of Zagreb School of Medicine & University Hospital Centre Zagreb, Zagreb, Croatia; Prof. Anne Pavy-LeTraon, Department of Neurology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; Prof. Walter Struhal, Department of Neurology, Karl Landsteiner University of Health Sciences & University Hospital Tulln, Tulln, Austria; Prof. Jalesh N. Panicker, Department of Uro-Neurology, The National Hospital for Neurology & UCL Queen Square Institute of Neurology, London, UK; Prof. Cristian Falup-Pecurariu, Department of Neurology, Faculty of Medicine, Transilvania University, Brasov, Romania; Prof. Horacio Kaufmann, Department of Neurology, Dysautonomia Centre, New York University School of Medicine, New York, USA; Prof. K Ray Chaudhuri, Parkinson Foundation International Centre of Excellence & Institute of Psychiatry, Psychology and Neuroscience, King’s College Hospital London, London, UK; Prof. Anette Schrag, Department of Clinical & Movement Neurosciences, UCL Institute of Neurology, London, UK; Prof. Tanya Gurevich, Movement Disorders Unit, Neurological Institute, Tel Aviv Sourasky Medical Centre & Sagol School of Neuroscience and Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; DDr. Iva Stankovic, Clinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia

Research Group Movement Disorders

Andrew Lees, University College London, Reta Lila Weston Institute, London, UK; Walter Maetzler, UKSH Universitätsklinikum Schleswig-Holstein, Germany; Avner Thaler , Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; David Vaillancourt, Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA; Horacio Kaufmann and Un Kang, Department of Neurology, Dysautonomia Centre New York University School of Medicine New York New York USA; Wolfgang Singer, Department of Neurology, Mayo Rochester, Minnesota, USA; Daniel Claassen, Vanderbilt University Medical Centre, Department of Neurology, Nashville, Tennessee; Björn Eskofier und Heiko Gaßner, Friedrich Alexander University Erlangen, Germany; Jochen Klucken, University of Luxembourg, Department of Digital Medicine, Luxembourg; Aldo Quattrone, Neuroscience Research Centre, University “Magna Graecia”, Catanzaro, Italy; Ganluigi Zanusso, Department of Neurosciences, Biomedicine and Movement Sciences University of Verona, Verona, Italy; Eduardo Tolosa Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain; Michael Zech, Institute of Neurogenomics, Helmholtz Zentrum, Munich, Germany

Research Group at the Centre for Rare Movement Disorders

PD Michael Zech, Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany (Dystonia, WGS, WES in movement disorders); Prof. B Brais / Prof. R. Lapiana / Dr. D. Pellerin (FGF14 research group), Neurogenetics Unit, Mc University Montreal); Henry Houlden (ICU London (Genetics in Movement Disorders); ERN-RND Ataxia & HSP/Dystonia & paroxysmal movement disorders/ transition working groups (within the cooperation in particular with Paris Brain Institute/Prof. A. Durr, Neuropädiatrie Barcelona/Dr. J Ortigoza Escobar, Bambin Gesu´ Rome/Prof. Enrico Bertini, Univ.-Klinik Neurologie Tübingen / Prof. Ludger Schols, Besta Institute Milan / Prof. C. Mariotti); Friedreich´s Ataxia Global Clinical Consortium (international cooperation from34 centres mit US, Kanada, Indien, Europa und Australien); Treat-HSP Consortium (Prof. R. Schüle-Freyer, Neurologie Heidelberg; Europäisches HSP Netzwerk ); Spastax Consortium (Paris Brain Institute/Prof. A. Durr); EFACTS consortium (Friedreich ataxia research for translational studies); Global SCA Initiative (international cooperation with centres in the US, Europe and Australia); ENIGMA (international cooperation on imaging with centres in the US Europe and Australia); Solve-RD (EU, genetics in unsolved rare disease; Tübingen)

Research Group Neurocritical Care and Infectious Diseases of the Nervous System

Johannes Kepler University Linz, Department of Neurology; Medical University of Graz, Centre for Medical Research; Core Facility Mass Spectrometry, CENTER-TBI Study Group (Europe); Curing Coma Campaign Collaborators (International); EURECA Investigator Study Group (Europe); Neurocore-iMMM Research Group (International); VENTIBRAIN Study Group (International)

Research Group Neuropsychology

Prof. Manuela Piazza, CIMeC Centre for Mind/Brain Sciences, University of Trento, Italy ; Prof. Demis Basso, Faculty of Education, University of Bolzano, Italy; Prof. Patrick Lemaire, Aix Marseille Universitè, France; Prof. Daniel Baumgarten & Dr. Johannes Vorwerk, Institute for Electrical and Biomedical Engineering, UMIT, Austria; FH-Prof. Yeongmi Kim, Department of Mechatronics & Smart Technologies, Management Centre Innsbruck, Austria

Research Group Multiple Sclerosis and Neuroimmunology

Maria Willrich, Mayo Clinic, Rochester, Minnesota, USA; Gabriel Bsteh, Med Uni Wien, Österreich

Michael Khalil, Med Uni Graz, Österreich; Hayrtettin Tumani, Uni Ulm, Ulm Deutschland

Sharmilee Gnanapavan, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Petra Nytrova, –         Charles University, Department of Neurology, Prague, Czech Republic; Georgina Arrambide, Department of Neurology/ Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autónoma de Barcelona, Barcelona, Spain; Prof. Janette Walde, Department of Statistics, University of Innsbruck; Prof. Dr. Tania Kümpfel, Institut für klinische Neuroimmunologie, LMU KLINIKUM der University of Munich

Research Group Neurooncology

Raymond Y. Huang, MD, PhD, Division Chief, Neuroradiology, Associate Professor, Harvard Medical School, USA, for the RANO (Response Assessment in Neurooncology) Research Group) radiomics; Univ.-Prof.in Ghazaleh Tabatabei, Head of Neurology, University Tübingen, Germany for the DivINe Group; Adelheid Woehrer, MD PhD, Institute of Pathology, Neuropathology and Molecular Pathology at the Medical University of Innsbruck; Univ. Prof. Dr. med. Univ. Matthias Preusser, Head of “klinische Abteilung für Onkologie” at Medical University Campus Vienna, Vienna, Austria, senior lead of the ATTRACT trial (an austrian multidisciplinary study investigating personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain Tumor TheRApy Clinical Trial (ATTRACT); Assoc. Prof.in Priv. Doz.in Dr. med. Univ. Anna Sophie Berghoff, Head of “Internistische Neuroonkologie”, Medical University Campus Vienna; Univ.-Prof. Dr. Johannes Hainfellner, Division of Neuropathology and Neurochemistry (Obersteiner Institute), Department of Neurology, Medical University Campus Vienna as Head of the SANO (Society of Austrian Neurooncology) Research Group

Research Group Neuromuscular Disorders

Prof. Dr. Thomas Meyer, Outpatient clinic for ALS and other motor neuron diseases at the (Charité, University Medical Centre, Berlin); Prof. Dr. Hakan Cetin, Department of Neurology, Medical University Vienna; Priv.-Doz. Dr. Martin Krenn, Department of Neurology, Medical University Vienna;

Prof. Dr. Romana Höftberger, Department of Neuropathology and Neurochemistry Medical University Vienna

Research Group Experimental Neurology

International Panel for NMOSD Diagnosis (IPND), multinational (Markus Reindl); International MOGAD Panel, multinational (Markus Reindl)

Research Group Translational Neurodegeneration Research

Prof. Veerle Baekelandt, Department of Neurosciences, KU Leuven, Leuven, Belgium; Distinguished Professor Charles Dinarello, University of Colorado Denver – Anschutz Medical Campus, Denver, CO, USA; Prof. Vik Khurana, Harvard Stem Cell Institute, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA; DDr. Sonja Scholz, Neurodegenerative Diseases Research Unit, NINDS, NIH, Bethesda, USA; Ass. Prof. Dr. Maria Xilouri, Biomedical Research Foundation, Academy of Athens (BRFAA), Greece ; Prof. Dr. Valtteri Kaasinen, Clinical Neurosciences, University of Turku, Finland; Prof. Dr. Matt Huentelman, Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA; Prof. Dr. Kohji Fukunaga, Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan; Prof. Dr. Gal Bitan, Department of Neurology, David Geffen School of Medicine, Brain Research Institute, Molecular Biology Institute, University of California, Los Angeles, CA, USA; Prof. Dr. David I Finkelstein, Florey Institute of Neuroscience and Mental Health and the University of Melbourne, Parkville, Victoria, Australia; Dr. Diana Cash, Department of Neuroimaging, Institute of Psychology, Psychiatry and Neuroscience, King’s College London, London, UK; Prof. Dr. Per Svenningsson, Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden